CTRI/2022/10/046782尚未招募未知
Impact of Injectable contraceptive-DepotMedroxyprogesterone Acetate (DMPA) Administration on selected outcome measures.
Rajalakshmi R0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Female taking Injectable Contraceptive-DMPA
排除标准
- •Undiagnosed Vaginal Or Urinary Tract Bleeding
- •Breast Cancer
- •Poorly Controlled Hypertension
- •Multiple Cardiovascular Risk Factors
- •Sever Hepatic Dysfunction
研究者
相似试验
招募中
4 期
Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell DiseaseSickle Cell Disease (SCD)Vaso-Occlusive Pain Episode in Sickle Cell DiseaseNCT06665997University of Pennsylvania65
招募中
不适用
The WHICH injection study (Part 1)Mental and Behavioural DisordersPACTR202009758229976niversity of Fort Hare520
尚未招募
3 期
Comparing two drugs for a treatmentCTRI/2024/03/064357SRM college of pharamacy
已完成
不适用
Depot-medroxy Progesterone Acetate Injectable Contraceptives in Lactating Women 1st Week Versus 6 Week Postpartum InitiationComplications of DMPA Injectable ContraceptivesNCT06100783Assiut University120
招募中
3 期
Effect of Medroxy progesteron in Chronic Obstructive Pulmonary Disease (COPD) exacerbatioChronic Obstructive Pulmonary Disease(COPD) Exacerbation.Chronic obstructive pulmonary disease with acute exacerbation, unspecifiedJ44.1IRCT20211031052922N1Esfahan University of Medical Sciences70